This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Countdown to Philip Morris (PM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of Philip Morris (PM) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Philip Morris (PM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Philip Morris (PM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MO Stock Falls 4% in a Month: Is Now the Right Time to Buy?
by Ansuiya Mohta
MO's strong position in the smoke-free market, cost-savings and favorable earnings outlook position it as an attractive stock with growth potential.
Philip Morris Resilient on Smoke-Free Transition Efforts and Pricing
by Zacks Equity Research
PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth amid currency-related challenges.
Here's Why Philip Morris (PM) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Altria Stock Trading Cheaper Than Industry: What's the Next Best Move?
by Ansuiya Mohta
MO shows resilience through strategic partnerships and pricing power amid challenges from illicit products and declining cigarette volumes.
Zacks Investment Ideas feature highlights: Exxon Mobil, Philip Morris International and AT&T
by Zacks Equity Research
Exxon Mobil, Philip Morris International and AT&T are part of the Zacks Investment Ideas article.
3 Must Buy Stocks Ahead of a Market Correction
by Ethan Feller
Exxon Mobil, AT&T and Philip Morris offer investors a defensive allocation in an uncertain market
Altria Stock Reaches 52-Week High: Time to Capitalize or Wait?
by Ansuiya Mohta
Altria's smoke-free strategy and pricing power make it a compelling option for value-focused investors despite challenges from declining cigarette volumes.
Top Research Reports for Abbott, BlackRock & ConocoPhillips
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BlackRock, Inc. (BLK) and ConocoPhillips (COP), as well as two micro-cap stocks, NetSol Technologies, Inc. (NTWK) and Optex Systems Holdings, Inc (OPXS).
Why Is Philip Morris (PM) Down 0.8% Since Last Earnings Report?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PM Stock Rallies 30% in 6 Months: What Should Investors Do Next?
by Ansuiya Mohta
Philip Morris is driving strong growth through its smoke-free transformation, supported by innovation, global expansion, pricing power, and disciplined cost management.
Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPS
The Zacks Analyst Blog JPMorgan, Philip Morris and The Progressive
by Zacks Equity Research
JPMorgan, Philip Morris and The Progressive are included in this Analyst Blog.
The Zacks Analyst Blog Philip Morris, Altria and British American Tobacco
by Zacks Equity Research
Philip Morris, Altria and British American Tobacco are included in this Analyst Blog.
Top Research Reports for JPMorgan, Philip Morris & Progressive
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Philip Morris International Inc. (PM) and The Progressive Corporation (PGR).
3 Tobacco Stocks to Watch as Smoke-Free Trends Ignite Growth
by Vrishali Bagree
Tobacco industry leaders like PM, MO and BTI are investing heavily in smoke-free products to align with health trends and regulatory shifts. Despite declining cigarette sales, strong pricing power and RRP growth support a sustainable outlook.
Are Consumer Staples Stocks Lagging Freshpet (FRPT) This Year?
by Zacks Equity Research
Here is how Freshpet (FRPT) and Philip Morris (PM) have performed compared to their sector so far this year.
Philip Morris (PM) Is Up 8.03% in One Week: What You Should Know
by Zacks Equity Research
Does Philip Morris (PM) have what it takes to be a top stock pick for momentum investors? Let's find out.
MO Q3 Earnings Top Estimates on Pricing Amid Low Cigarette Volumes
by Zacks Equity Research
Altria's Q3 results reflect strong pricing, while cigarette shipment volumes remain soft. Management announces the Optimize & Accelerate initiative.
Zacks Investment Ideas feature highlights: Pfizer, Philip Morris and Tenet Healthcare
by Zacks Equity Research
Pfizer, Philip Morris and Tenet Healthcare are part of the Zacks Investment Ideas article.
3 Stocks to Buy Following Robust Quarterly Results
by Derek Lewis
Throughout the Q3 reporting cycle, several companies, including Pfizer, Philip Morris, and Tenet Healthcare, have stolen the spotlight, with each raising guidance.
The Zacks Analyst Blog Rowe Price, Duke Energy, Philip Morris International and Regions Financial
by Zacks Equity Research
Rowe Price, Duke Energy, Philip Morris International and Regions Financial are included in this Analyst Blog.
Buy 4 High-Yield, Large-Cap Dividend Stocks to Beat Volatile Markets
by Nalak Das
Investment in big corporates with regular dividend payments and a favorable Zacks Rank should be fruitful. Four such stocks are: TROW, DUK, PM, RF.
Is Altria Stock a Buy, Sell or Hold at a P/S Multiple of 4.2X?
by Vrishali Bagree
Altria struggles with challenges in the Smokeable Products unit, driven by economic pressures on consumers and the rise of illegal e-vapor alternatives.